Skip to main content
logo
Wanbury Limited (NSE:WANBURY)
India flag India · Delayed Price · Currency is INR
268.45
-0.45 (-0.17%)
Aug 1, 2025, 3:29 PM IST

Chimerix Revenue

In the fiscal year ending March 31, 2025, Wanbury had annual revenue of 6.00B INR with 4.15% growth. Wanbury had revenue of 1.72B in the quarter ending March 31, 2025, with 23.38% growth.

Revenue
6.00B
Revenue Growth
+4.15%
P/S Ratio
1.47
Revenue / Employee
4.02M
Employees
1,491
Market Cap
8.84B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20256.00B238.64M4.15%
Mar 31, 20245.76B760.03M15.21%
Mar 31, 20235.00B-115.39M-2.26%
Mar 31, 20225.11B1.19B30.23%
Mar 31, 20213.93B250.63M6.82%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries537.09B
Divi's Laboratories93.60B
Cipla274.80B
Mankind Pharma129.10B
Apollo Hospitals Enterprise217.94B
Zydus Lifesciences232.42B
Fortis Healthcare77.86B
Aurobindo Pharma317.24B
Revenue Rankings

Wanbury News

More News